Callan JMB faces Nasdaq delisting after failing equity rule; hearing requested
Callan JMB Inc. received a Nasdaq Staff determination on October 12, 2026 that it did not meet the terms of an extension to regain compliance with the $2,500,000 minimum stockholders' equity requirement, because it could not complete its capital raising initiatives. The company requested a hearing before a Nasdaq Hearings Panel on October 14, 2026, which stays the planned trading suspension, but the company says there is no assurance the Panel will grant continued listing.
Key points
- Nasdaq Listing Rule 5550(b)(1) requires at least $2,500,000 in stockholders' equity for continued listing on The Nasdaq Capital Market.
- Absent an appeal, trading in the common stock would have been suspended at the opening of business on October 21, 2026, and a Form 25-NSE would have been filed.
- The company requested a hearing before a Nasdaq Hearings Panel on October 14, 2026, which stays the suspension and the Form 25-NSE pending the Panel's decision.
- The filing states the Panel may not grant continued listing and the company may not regain compliance.
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 16, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.